Cancer Family
Trophoblastic Tumor
CI-CAN-00000376Explore in graph →
Non-malignant12 active trials1 approved drugs
Loading cancer entity…
Cancer Family
CI-CAN-00000376Explore in graph →
Clinical trials
82 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02664961 | Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) | terminated | Phase 2 | 3 | Tracon Pharmaceuticals Inc.INDUSTRY | 1 | Jul 23, 2019 | clinicaltrials |
| NCT00096187 | Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy | terminated | Phase 2 | 55 | Gynecologic Oncology GroupNETWORK | 1 | Apr 12, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Jul 23, 2019source: clinicaltrials